The Biomarkers of Cd4+ T Regulatory Cells Associated with Tumour Immune Escape
Open Access
- 28 October 2020
- journal article
- Published by Peertechz Publications Private Limited in International Journal of Immunotherapy and Cancer Research
- Vol. 6 (1), 028-034
- https://doi.org/10.17352/2455-8591.000028
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Clinical Application of Anti-CCR4 Monoclonal AntibodyOncology, 2015
- Interleukin-28B Plays a Therapeutic Role on Mouse U14 Cervical Cancer Cells by Down-Regulating CD4+CD25+FoxP3+Regulatory T Cells In VivoInternational Journal of Gynecologic Cancer, 2015
- Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer PatientsClinical Cancer Research, 2015
- Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patientsCancer Immunology, Immunotherapy, 2015
- Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive ActivityCancer Immunology Research, 2015
- CD4+CD25+CD127low Regulatory T Cells Play Predominant Anti-Tumor Suppressive Role in Hepatitis B Virus-Associated Hepatocellular CarcinomaFrontiers in Immunology, 2015
- Methionine Enkephalin (MENK) Inhibits tumor growth through regulating CD4+Foxp3+ Regulatory T cells (Tregs) in miceCancer Biology & Therapy, 2015
- Inhibition of Foxp3 in cancer cells induces apoptosis of thyroid cancer cellsMolecular and Cellular Endocrinology, 2015
- Regulatory T cells in cancer immunotherapyCurrent Opinion in Immunology, 2014
- Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II StudyJournal of Clinical Oncology, 2012